HU223343B1
(hu)
*
|
1991-05-20 |
2004-06-28 |
Novartis Ag. |
Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
|
US6005001A
(en)
*
|
1991-05-20 |
1999-12-21 |
Novartis Ag (Formerly Sandoz Ag) |
Pharmaceutical composition
|
US5916596A
(en)
*
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US20020173547A1
(en)
|
1994-03-22 |
2002-11-21 |
Jones Christopher Buchan |
Pharmaceuticals compositions
|
MY113046A
(en)
*
|
1994-03-22 |
2001-11-30 |
Astrazeneca Uk Ltd |
Pharmaceutical compositions
|
US5731356A
(en)
*
|
1994-03-22 |
1998-03-24 |
Zeneca Limited |
Pharmaceutical compositions of propofol and edetate
|
GB9405593D0
(en)
*
|
1994-03-22 |
1994-05-11 |
Zeneca Ltd |
Pharmaceutical compositions
|
IT1269977B
(it)
|
1994-07-01 |
1997-04-16 |
Archimica Spa |
Purificazione del propofol
|
IT1270093B
(it)
*
|
1994-09-28 |
1997-04-28 |
Zambon Spa |
Processo per la purificazione di 2,6-diisopropilfenolo
|
CN1106192C
(zh)
*
|
1995-03-17 |
2003-04-23 |
曾尼卡有限公司 |
含2,6-二异丙基苯酚和乙二胺四乙酸盐的水包油型乳液
|
CN100450473C
(zh)
*
|
1995-03-17 |
2009-01-14 |
曾尼卡有限公司 |
无菌医药组合物
|
WO1997010814A1
(en)
*
|
1995-09-18 |
1997-03-27 |
Vesifact Ag |
Propofol nanodispersions
|
AU709262B2
(en)
|
1995-10-17 |
1999-08-26 |
Board Of Regents, The University Of Texas System |
Insoluble drug delivery
|
US5637625A
(en)
*
|
1996-03-19 |
1997-06-10 |
Research Triangle Pharmaceuticals Ltd. |
Propofol microdroplet formulations
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US7255877B2
(en)
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
DE19709704C2
(de)
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
CH692322A5
(it)
*
|
1997-05-26 |
2002-05-15 |
Westy Ag |
Formulazione iniettabile limpida di Propofol.
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
DE19757224A1
(de)
|
1997-12-22 |
1999-07-01 |
Bayer Ag |
Verfahren und Vorrichtung zur in-situ-Formulierung einer Arzneistofflösung zur parenteralen Applikation
|
AU750040B2
(en)
*
|
1998-02-10 |
2002-07-11 |
Sicor Inc. |
Propofol composition containing sulfite
|
ES2201673T3
(es)
*
|
1998-02-11 |
2004-03-16 |
Rtp Pharma Corporation |
Combinacion de esteroides y acidos grasos poiinsaturados para el tratamiento de estados inflamatorios.
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
CN1245955C
(zh)
|
1998-05-29 |
2006-03-22 |
斯凯伊药品加拿大公司 |
热保护微粒组合物及其最终蒸汽灭菌的方法
|
DE69912441T2
(de)
|
1998-08-19 |
2004-08-19 |
Skyepharma Canada Inc., Verdun |
Injizierbare wässerige propofoldispersionen
|
US6150423A
(en)
|
1998-10-15 |
2000-11-21 |
Phoenix Scientific, Inc. |
Propofol-based anesthetic and method of making same
|
US6028108A
(en)
*
|
1998-10-22 |
2000-02-22 |
America Home Products Corporation |
Propofol composition comprising pentetate
|
US6140374A
(en)
*
|
1998-10-23 |
2000-10-31 |
Abbott Laboratories |
Propofol composition
|
RU2233654C2
(ru)
|
1998-11-20 |
2004-08-10 |
Ртп Фарма Инк. |
Диспергируемые стабилизированные фосфолипидом микрочастицы
|
US6177477B1
(en)
*
|
1999-03-24 |
2001-01-23 |
American Home Products Corporation |
Propofol formulation containing TRIS
|
US6100302A
(en)
*
|
1999-04-05 |
2000-08-08 |
Baxter International Inc. |
Propofol formulation with enhanced microbial characteristics
|
ES2261210T3
(es)
*
|
1999-06-21 |
2006-11-16 |
Kuhnil Pharmaceutical Co., Ltd. |
Comoposicion anestesica para inyeccion intravenosa que comprende propofol.
|
GB2359747B
(en)
*
|
2000-02-29 |
2002-04-24 |
Maelor Pharmaceuticals Ltd |
Anaesthetic formulations
|
KR100386397B1
(ko)
*
|
2000-04-19 |
2003-06-02 |
센츄론(주) |
투명한 프로포폴 주사제
|
AU2001257115B2
(en)
|
2000-04-20 |
2005-01-27 |
Rtp Pharma Inc. |
Improved water-insoluble drug particle process
|
EP2036540A3
(en)
|
2000-06-16 |
2009-12-16 |
Jagotec AG |
Improved injectable dispersions of propofol
|
DE10041479A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
|
DE10041478A1
(de)
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung
|
WO2002017883A2
(en)
|
2000-08-31 |
2002-03-07 |
Rtp Pharma Inc. |
Milled particles
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
EP1361867B1
(en)
*
|
2001-02-22 |
2007-03-21 |
Jagotec AG |
Fibrate-statin combinations with reduced fed-fasted effects
|
US7244703B2
(en)
|
2001-06-22 |
2007-07-17 |
Bentley Pharmaceuticals, Inc. |
Pharmaceutical compositions and methods for peptide treatment
|
JP4127757B2
(ja)
*
|
2001-08-21 |
2008-07-30 |
株式会社エヌ・ティ・ティ・ドコモ |
無線通信システム、通信端末装置、及びバースト信号送信方法
|
GB0120702D0
(en)
*
|
2001-08-24 |
2001-10-17 |
Maelor Pharmaceuticals Ltd |
Anaesthetic formulations
|
CA2459125A1
(en)
|
2001-09-26 |
2003-04-03 |
Theravance, Inc. |
Substituted phenol compounds useful for anesthesia and sedation
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
IL160570A0
(en)
|
2001-09-26 |
2004-07-25 |
Baxter Int |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
GB0124071D0
(en)
*
|
2001-10-08 |
2001-11-28 |
Kbig Ltd |
Improvement in the administration of high boiling point aneasthetics
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
CA2470500C
(en)
*
|
2001-12-28 |
2012-05-15 |
Guilford Pharmaceuticals, Inc. |
Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
|
JP3931680B2
(ja)
*
|
2002-02-18 |
2007-06-20 |
株式会社日本自動車部品総合研究所 |
車両の直進判別装置
|
WO2004039360A1
(en)
*
|
2002-10-29 |
2004-05-13 |
Transform Pharmaceuticals, Inc. |
Aqueous 2,6-diisopropylphenol pharmaceutical compositions
|
US7550155B2
(en)
*
|
2002-07-29 |
2009-06-23 |
Transform Pharmaceuticals Inc. |
Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
|
AU2003261274C1
(en)
*
|
2002-07-29 |
2009-02-12 |
Transform Pharmaceuticals, Inc. |
Aqueous 2,6-diisopropylphenol pharmaceutical compositions
|
US20040220283A1
(en)
*
|
2002-07-29 |
2004-11-04 |
Transform Pharmaceuticals, Inc. |
Aqueous 2,6-diisopropylphenol pharmaceutical compositions
|
US20040171691A1
(en)
*
|
2002-10-29 |
2004-09-02 |
Transform Pharmaceuticals, Inc. |
Propofol with cysteine
|
PE20040698A1
(es)
*
|
2002-11-26 |
2004-10-30 |
Maruishi Pharma |
Derivados de isoindolina
|
US20040225022A1
(en)
*
|
2003-05-09 |
2004-11-11 |
Desai Neil P. |
Propofol formulation containing reduced oil and surfactants
|
US8476010B2
(en)
|
2003-07-10 |
2013-07-02 |
App Pharmaceuticals Llc |
Propofol formulations with non-reactive container closures
|
US8546453B2
(en)
|
2003-08-14 |
2013-10-01 |
Rensheng Zhang |
Propofol compositions and methods for reducing pain associated with propofol injection
|
ITMI20032054A1
(it)
*
|
2003-10-22 |
2005-04-23 |
Monteres S R L |
Processo per la preparazione di sospensioni farmaceutiche da inalare.
|
CA2547990C
(en)
|
2003-12-08 |
2011-08-02 |
Bentley Pharmaceuticals, Inc. |
Pharmaceutical compositions and methods for insulin treatment
|
JP2007520555A
(ja)
*
|
2004-02-05 |
2007-07-26 |
バクスター・インターナショナル・インコーポレイテッド |
自己安定化剤の使用により調製された分散剤
|
MX2007015183A
(es)
*
|
2005-06-14 |
2008-02-19 |
Baxter Int |
Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco.
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
WO2007143038A1
(en)
*
|
2006-05-30 |
2007-12-13 |
Trustees Of Columbia University In The City Of New York |
Method of mediating airway smooth muscle construction due to airway irritation
|
WO2008008492A2
(en)
*
|
2006-07-13 |
2008-01-17 |
University Of Iowa Research Fdtn. |
Hydrofluoroalkyl phenols having anesthetic properties
|
WO2008080047A2
(en)
*
|
2006-12-23 |
2008-07-03 |
Baxter International Inc. |
Magnetic separation of fine particles from compositions
|
JP2010526827A
(ja)
*
|
2007-05-09 |
2010-08-05 |
ファーマコフォア,インク. |
治療用化合物
|
DK2301908T3
(da)
|
2007-05-09 |
2014-09-15 |
Sowood Healthcare Llc |
(-)-stereoisomer af 2,6-di-sec-butylphenol og analoger dertil til frembringelse af en antiemetisk effekt, behandling af kvalme og opkastning og behandling af migræne
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US20080293814A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
US20090198145A1
(en)
*
|
2008-02-06 |
2009-08-06 |
Chow Harrison |
Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep
|
JP2017531011A
(ja)
|
2014-10-16 |
2017-10-19 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
麻酔のための新規の方法、化合物および組成物
|